Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. FDX
5. IBM
6. MU
7. META
8. USO
9. NVDA
10. BLZE

Go back to Ocular Therapeutix™ Announces Additional Positive Week 52 Data from Landmark SOL-1 Phase 3 Trial of AXPAXLI™ in Wet AMD
(NASDAQ: OCUL) Delayed: 10.12 +0.15 (1.50%)
Previous Close $9.97    52 Week High $14.50 
Open $9.83    52 Week Low $4.04 
Day High $10.62    P/E N/A 
Day Low $9.80    EPS $0.00 
Volume 2,756,642